Global Bio-chem Technology Group Company Limited

0809.HK · HKSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market CapHK$946,440HK$944,185HK$1,389,555HK$1,104,518
- CashHK$85,470HK$88,135HK$41,766HK$21,810
+ DebtHK$3,691,036HK$5,449,538HK$8,910,280HK$8,444,273
Enterprise ValueHK$4,552,006HK$6,305,588HK$10,258,069HK$9,526,981
RevenueHK$2,001,095HK$1,373,938HK$12,711HK$746,551
% Growth45.6%10,709%-98.3%
Gross ProfitHK$218,682HK$43,637-HK$263,374HK$48,351
% Margin10.9%3.2%-2,072%6.5%
EBITDAHK$16,853HK$4,693,209-HK$469,064HK$785,633
% Margin0.8%341.6%-3,690.2%105.2%
Net IncomeHK$769,598HK$4,224,593-HK$1,443,068-HK$400,801
% Margin38.5%307.5%-11,352.9%-53.7%
EPS Diluted0.0860.47-0.16-0.045
% Growth-81.7%393.8%-255.6%
Operating Cash FlowHK$76,044-HK$50,461-HK$88,010-HK$475,207
Capital ExpendituresHK$0-HK$43,776-HK$6,176-HK$25,812
Free Cash FlowHK$76,044-HK$94,237-HK$94,186-HK$501,019
Global Bio-chem Technology Group Company Limited (0809.HK) Financial Statements & Key Stats | AlphaPilot